Publications by authors named "Sabela Recalde"

Claim this Profile
C
Correction: Mammographic density and breast cancer pathological subtypes by menopausal status and body mass index.
Julia Fernández-Morata, Marina Pollán, Nerea Fernández de Larrea-Baz, Vanessa Pachón-Olmos, Javier García-Pérez, Sabela Recalde

Breast Cancer Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mammographic density and breast cancer pathological subtypes by menopausal status and body mass index.
Julia Fernández-Morata, Marina Pollán, Nerea Fernández de Larrea-Baz, Vanessa Pachón-Olmos, Javier García-Pérez, Sabela Recalde

Breast Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Atezolizumab plus paclitaxel and bevacizumab as first-line treatment of advanced triple-negative breast cancer: the ATRACTIB phase 2 trial.
María Gion, Isabel Blancas, Patricia Cortez-Castedo, Alfonso Cortés-Salgado, Frederik Marmé, Sabela Recalde

Nat Med· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevention of sacituzumab govitecan-related neutropenia and diarrhea in patients with HER2-negative advanced breast cancer (PRIMED): an open-label, single-arm, phase 2 trial.
José Manuel Pérez-García, María Gion, Manuel Ruiz-Borrego, Isabel Blancas, Elena López-Miranda, Sabela Recalde

EClinicalMedicine· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research Recommendations in Women with Breast Cancer.
Vanessa Pachón Olmos, Marina Pollán, Nerea Fernández de Larrea-Baz, Julia Fernández-Morata, Emma Ruiz-Moreno, Sabela Recalde

Cancers (Basel)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Prognostic Value of Cytoplasmic and Stromal Caveolin-1 in Early Triple-Negative Breast Cancer Undergoing Neoadjuvant Chemotherapy.
Iris Teruel, Eva Castellà, Sabela Recalde, Gemma Viñas, Anna Petit

Int J Mol Sci· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Elderly patients with hormone receptor-positive HER2-negative metastatic breast cancer treated with CDK4/6 inhibitors in a multicentre cohort.
Helena Pla, Eudald Felip, Verónica Obadia, Sonia Pernas, Gemma Viñas, Sabela Recalde

Clin Transl Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast Cancer Patient's Outcomes after Neoadjuvant Chemotherapy and Surgery at 5 and 10 Years for Stage II-III Disease.
Catalina Falo, Juan Azcarate, Sergi Fernandez-Gonzalez, Xavier Perez, Ana Petit, Sabela Recalde

Cancers (Basel)· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic characterization and tumor evolution in paired samples of metaplastic breast carcinoma.
Agostina Stradella, Pablo Gargallo, Mónica Cejuela, Anna Petit, Jan Bosch-Schips, Sabela Recalde

Mod Pathol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can we avoid axillary lymph node dissection in N2 breast cancer patients with chemo-sensitive tumours such as HER2 and TNBC?
Amparo Garcia-Tejedor, Sergi Fernandez-Gonzalez, Raul Ortega, Miguel Gil-Gil, Hector Perez-Montero, Sabela Recalde

Breast Cancer Res Treat· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center.
Milana Bergamino Sirvén, Adela Fernández-Ortega, Agostina Stradella, Idoia Morilla, Catalina Falo, Sabela Recalde

BMC Pharmacol Toxicol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis